Search Result
Results for "
glycyl
" in MedChemExpress (MCE) Product Catalog:
5
Isotope-Labeled Compounds
| Cat. No. |
Product Name |
Target |
Research Areas |
Chemical Structure |
-
- HY-153360
-
|
|
Drug-Linker Conjugates for ADC
Topoisomerase
|
Cancer
|
|
MC-GGFG-AM-(10Me-11F-Camptothecin) is a linker-payload conjugate used to synthesize ZW251. ZW251 an antibody-drug conjugate (ADC) targeting human GPC3. ZW251 consists of a humanized IgG1 antibody conjugated to a novel camptothecin-based topoisomerase 1 inhibitor, ZD06519, via a linker. The linker is the maleimide anchor and a glycyl glycyl phenylalanyl glycine (GGFG)-aminomethyl (AM) cleavable linker. ZW251 has high affinity with human and cynomolgus monkey GPC3. ZW251 displays rapid internalization in GPC3-expressing HCC cell lines, and bystander-mediated killing of GPC3 negative cancer cells .
|
-
-
- HY-W016887
-
|
H-Gly-Pro-OH; Gly-Pro
|
Endogenous Metabolite
Apoptosis
|
Metabolic Disease
Cancer
|
|
Glycyl-L-proline (H-Gly-Pro-OH) is a dipeptide. Glycyl-L-proline can induce MCF-7 cells apoptosis. Glycyl-L-proline can enhance the inhibitory effect of the PRODH/POX knockout on collagen and DNA biosynthesis. Glycyl-L-proline can inhibit Gly-Sar and L-proline transport. Glycyl-L-proline can be used for the researches of cancer and metabolic disease, such as breast cancer .
|
-
-
- HY-128995AS
-
|
glycyl-DX-8951-d5 hydrochloride; Exatecan analog 2-d5 hydrochloride
|
Isotope-Labeled Compounds
ADC Payload
Topoisomerase
|
Cancer
|
|
Glycyl-Exatecan-d5 (Glycyl-DX-8951-d5) hydrochloride is deuterium labeled Glycyl-Exatecan (HY-128995A). Glycyl-Exatecan (Glycyl-DX-8951), a derivative of Exatecan (HY-13631), is an anticancer agent. Glycyl-Exatecan has significantly antitumor activity. Glycyl-Exatecan can be used for cancers like solid tumors research.
|
-
-
- HY-W009592
-
|
glycyltyrosine; Gly-Tyr; H-Gly-Tyr-OH
|
Amino Acid Derivatives
|
Others
|
|
Glycyl-L-tyrosine is a synthetic dipeptide that can be used as a food additive for tyrosine supplementation .
|
-
-
- HY-117541
-
|
glycyl-L-glutamine
|
Others
|
Neurological Disease
|
|
Glycyl-glutamine (Glycyl-L-glutamine), as a enzymatic cleavage product of β-endorphin, is apparently an endogenous antagonist of beta-endorphin(1-31) in several systems . Glycyl-glutamine (Glycyl-L-glutamine) is an activate and stable glutamine-containing neuropeptide over glutamine (Gln) .
|
-
-
- HY-125616
-
|
Biotinyl-GHK; Bio-GHK
|
Amyloid-β
Reactive Oxygen Species (ROS)
|
Neurological Disease
|
|
Biotinoyl tripeptide-1 (Biotinyl-GHK) is a biotinylating reagent linked to a GHK (glycyl-L-histidyl-L-lysine) tripeptide. Biotin tripeptide-1 is a bioactive peptide with hair care (improves the appearance and feel of hair) and hair growth effects. Biotinoyl tripeptide-1 has a certain affinity for streptavidin. Biotinoyl tripeptide-1 inhibits the production of ROS and has antioxidant effects. Biotinoyl tripeptide-1 reduces the production of carbonylated amyloid-β (Aβ) and inhibits Aβ aggregation. Biotinoyl tripeptide-1 can be used in the study of neurodegenerative diseases .
|
-
-
- HY-W013998
-
-
-
- HY-W016077
-
-
-
- HY-128995A
-
|
glycyl-DX-8951 TFA; Exatecan analog 2 TFA
|
Drug Derivative
|
Cancer
|
|
Glycyl-Exatecan TFA (Glycyl-DX-8951 TFA), a derivative of Exatecan (HY-13631), is an anticancer agent. Glycyl-Exatecan TFA has significantly antitumor activity. Glycyl-Exatecan TFA can be used for cancers like solid tumors research .
|
-
-
- HY-W141910
-
-
-
- HY-W040088
-
|
H-Ala-Leu-OH
|
Aminopeptidase
|
Metabolic Disease
|
|
L-Alanyl-L-leucine is a competitive inhibitor of small intestinal glycyl-L-leucine hydrolase with Ki values of 0.53 mM (phosphate buffer) or 0.22 mM (Tris buffer). L-Alanyl-L-leucine can be used for research on Hartnup disease and cystinuria .
|
-
-
- HY-108940
-
-
-
- HY-W016785
-
-
-
- HY-144250S
-
-
-
- HY-W014000
-
-
-
- HY-15720B
-
|
|
ROCK
Aurora Kinase
CaMK
|
Neurological Disease
|
|
Glycyl H-1152 hydrochloride (compound 18) is a glycyl derivative of Rho-kinase inhibitors H-1152 dihydrochloride. Glycyl H-1152 hydrochloride inhibits ROCKII, Aurora A, CAMKII and PKG, with IC50s of 0.0118, 2.35, 2.57 and 3.26 μM respectively. Glycyl H-1152 hydrochloride has higher selective than H-1152 hydrochloride .
|
-
-
- HY-W152604
-
|
Cyclo(leu-gly)
|
Dopamine Receptor
|
Neurological Disease
|
|
Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity. Cyclo(glycyl-L-leucyl) inhibits the development of Morphine induced pain relief as well as dopamine receptor supersensitivity in rats. Cyclo(glycyl-L-leucyl) has the potential for the prevention of tardive and/or L-DOPA (HY-N0304)-induced dyskinesias .
|
-
-
- HY-W014700
-
|
H-Gly-Glu-OH; Gly-Glu
|
Cholinesterase (ChE)
|
Neurological Disease
|
|
Glycyl-L-glutamic acid is a neurotrophic factor (NF) in vivo, and exerts function of maintenance of AChE content and activity. Glycyl-L-glutamic acid doesn’t act directly on AChE synthesis, and may prevent preganglionic neuronal degeneration .
|
-
-
- HY-W009592A
-
|
glycyltyrosine dihydrate; Gly-Tyr dihydrate; H-Gly-Tyr-OH dihydrate
|
Amino Acid Derivatives
|
Others
|
|
Glycyl-L-tyrosine dihydrate is a synthetic dipeptide that can be used as a food additive for tyrosine supplementation .
|
-
-
- HY-128994A
-
|
|
Drug Intermediate
|
Cancer
|
|
GGFG-Exatecan TFA is a synthetic intermediate for drug-linker conjugates used in antibody-drug conjugates (ADCs). GGFG-Exatecan TFA consists of a glycyl-glycyl-phenylalanyl-glycine (GGFG) tetrapeptide linker and a DNA topoisomerase I inhibitor Exatecan (HY-13631). GGFG-Exatecan TFA can be used for the study of cancer .
|
-
-
- HY-W016887R
-
|
H-Gly-Pro-OH (Standard); Gly-Pro (Standard)
|
Reference Standards
Endogenous Metabolite
|
Metabolic Disease
|
|
H-Gly-Pro-OH (Standard) is the analytical standard of H-Gly-Pro-OH. This product is intended for research and analytical applications. H-Gly-Pro-OH is an end product of collagen metabolism that is further cleaved by prolidase.
|
-
-
- HY-P1930A
-
|
|
Integrin
|
Inflammation/Immunology
|
|
Risuteganib hydrochloride is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide. Risuteganib hydrochloride is an anti-integrin that downregulates oxidative stress and restores homeostasis, and targets three integrin receptors that are implicated in dry age-related macular degeneration (AMD) in order to restore homeostasis in the retina .
|
-
-
- HY-W040088R
-
|
H-Ala-Leu-OH (Standard)
|
Reference Standards
Aminopeptidase
|
Metabolic Disease
|
|
L-Alanyl-L-leucine is an endogenous metabolite. This product is used for research and analytical applications. L-Alanyl-L-leucine is a competitive inhibitor of small intestinal glycyl-L-leucine hydrolase with Ki values of 0.53 mM (phosphate buffer) or 0.22 mM (Tris buffer). L-Alanyl-L-leucine can be used for research on Hartnup disease and cystinuria .
|
-
-
- HY-W013751
-
|
N-Fmoc-glycyl-L-valine
|
Drug Intermediate
|
Others
|
|
Fmoc-Gly-Val-OH (N-Fmoc-glycyl-L-valine) is a glycyl valine derivative, can be used for the synthesis of drugs or other compounds .
|
-
-
- HY-W854721
-
|
Manganese(III) Protoporphyrin IX Chloride
|
Heme Oxygenase (HO)
|
Metabolic Disease
|
|
Mn(III) protoporphyrin IX chloride is a metalloporphyrin. It induces mRNA expression of the genes encoding δ-aminolevulinate synthase and heme oxygenase (HO), enzymes that catalyze the rate-limiting steps of heme biosynthesis and degradation, respectively, in chick embryo liver cells when used at a concentration of 10 μM. Mn(III) protoporphyrin IX chloride-containing nanobialys have been used in magnetic resonance imaging (MRI) of fibrin clots in vitro. It has also been used in the synthesis of Mn(III) protoporphyrin IX-6(7)-glycyl-glycyl-L-histidine methyl ester (MnGGH), a metalloporphyrin conjugate with microperoxidase activity.
|
-
-
- HY-W013664
-
|
|
PROTAC Linkers
|
Cancer
|
|
Glycyl-l-serine is a PROTAC linker composed of glycine and serine. Glycyl-l-serine can be used in the synthesis of PROTACs, such as FPP29 (HY-P11228) .
|
-
-
- HY-W143241
-
-
-
- HY-148218
-
|
N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine
|
Amino Acid Derivatives
|
Metabolic Disease
|
|
Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanyl-D-alanine is a specific peptide substrate of Streptomyces R1 d-alanyl-d-alanine(dd)-peptidases .
|
-
-
- HY-44370
-
|
|
ADC Linker
|
Cancer
|
|
(tert-Butoxycarbonyl)glycyl-glycyl-glycyl-glycyl-glycine is an ADC linker with a Boc group on the N terminus, and it is used for the development of antibody-drug conjugates (ADCs). The Boc group can be deprotected under mild acidic conditions to form the free amine.
|
-
-
- HY-128994
-
|
|
Drug Intermediate
|
Cancer
|
|
GGFG-Exatecan is a synthetic intermediate for drug-linker conjugates used in antibody-drug conjugates (ADCs). GGFG-Exatecan consists of a glycyl-glycyl-phenylalanyl-glycine (GGFG) tetrapeptide linker and a DNA topoisomerase I inhibitor Exatecan (HY-13631). GGFG-Exatecan can be used for the study of cancer .
|
-
-
- HY-W216585
-
|
N-glycyl-L-isoleucine
|
Biochemical Assay Reagents
|
Others
|
|
Glycyl-l-isoleucine (N-Glycyl-L-isoleucine) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
-
-
- HY-168772
-
|
H-Gly-Pro-OH TFA
|
Amino Acid Derivatives
|
Others
|
|
Glycyl-L-Proline TFA (H-Gly-Pro-OH TFA) is a dipeptide, which is composed of a glycine and a L-proline. Glycyl-L-Proline TFA can be used in research about the co-relationship between transmembrane potential/proton gradient and intestinal transport .
|
-
-
- HY-P1930
-
|
|
Integrin
|
Inflammation/Immunology
|
|
Risuteganib is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide. Risuteganib is an anti-integrin that downregulates oxidative stress and restores homeostasis, and targets three integrin receptors that are implicated in dry age-related macular degeneration (AMD) in order to restore homeostasis in the retina .
|
-
-
- HY-P991158
-
|
|
TGF-β Receptor
|
Neurological Disease
|
|
Rinvatercept, a fusion protein, is a glycyl (1)-chimeric N-terminal (1-108)-peptide (2-109) combined from the sequences of the extracellular domains of the human ACVR2A/B, and is fused via a G3 peptide linker (110-112) to an immunoglobulin G1 (IgG1) Fc fragment. Rinvatercept can be used for research of neuromuscular disease .
|
-
-
- HY-48321
-
|
|
ADC Linker
|
Cancer
|
|
N-Cbz-glycyl-glycyl-D-phenylalanine is a cleavable ADC linker.
|
-
-
- HY-W016785R
-
-
-
- HY-W273130
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glycyl-L-asparagine is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
-
-
- HY-W013998S
-
-
-
- HY-W009592R
-
|
glycyltyrosine (Standard); Gly-Tyr (Standard); H-Gly-Tyr-OH (Standard)
|
Amino Acid Derivatives
Reference Standards
|
Others
|
|
Glycyl-L-tyrosine (Standard) is the analytical standard of Cyclic somatostatin. This product is intended for research and analytical applications. Glycyl-L-tyrosine is a synthetic dipeptide that can be used as a food additive for tyrosine supplementation .
|
-
-
- HY-A0052S
-
|
Telaprevir, (R)-d4
|
Isotope-Labeled Compounds
|
Others
|
|
(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 is deuterated labeled (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide.
|
-
-
- HY-155444
-
|
|
Histamine Receptor
|
Cancer
|
|
AG5.0 is a bivalent hapten contains one HSG (histamine-succinyl-glycyl) group and one DTPA-indium group .
|
-
-
- HY-125161
-
|
|
Bacterial
Antibiotic
|
Others
|
|
MT0703 is an aminothiazolyl glycyl cephalosporin with a 1,5-dihydroxy-4-pyridone-2-carbonyl group and has good anti-Pseudomonas activity.
|
-
-
- HY-169810
-
|
|
Antibiotic
Bacterial
|
Infection
|
|
PKZ18 is an antibiotic and inhibits bacterial growth, with MIC values of 32-64 μg/mL against most Gram-positive bacteria. PKZ18 inhibits in vivo transcription and translation of glycyl-tRNA synthetase mRNA. PKZ18 selectively targets stem I specifier loops in Gram-positive bacteria and directly reduces T-box transcriptional read-through of the associated genes. PKZ18 prevents the codon-anticodon reading required for tRNA binding and is refractory to resistance .
|
-
-
- HY-128995
-
|
glycyl-DX-8951; Exatecan analog 2
|
Drug Metabolite
|
Cancer
|
|
Glycyl-Exatecan (Glycyl-DX-8951) is an active metabolite released from DE-310 by enzymatic cleavage of the spacer. Glycyl-Exatecan exerts anti-tumor activity in vivo. Glycyl-Exatecan can be used for solid tumor research .
|
-
-
- HY-W016077R
-
|
|
Reference Standards
Endogenous Metabolite
|
Others
|
|
Glycyl-L-leucine (Standard) is the analytical standard of Glycyl-L-leucine. This product is intended for research and analytical applications. Glycyl-l-leucine is a dipeptide that can be a common substrate for glycyl-leucine dipeptidase.
|
-
-
- HY-117247
-
|
|
DNA/RNA Synthesis
|
Infection
|
|
5,6,7,8-Tetrahydro-8-deazahomofolic acid is a potential thymidylate synthase (TS) inhibitor with inhibitory activity against other folate-related enzymes. 5,6,7,8-Tetrahydro-8-deazahomofolic acid showed mild growth inhibition against enterococci, lactic acid bacteria, and L1210 cells in culture. 5,6,7,8-Tetrahydro-8-deazahomofolic acid also showed weak inhibition against thymidylate synthase, dihydrofolate reductase, glycyl-ribonucleoside aminotransferase, and aminoimidazole-carboxyacyl-ribonucleoside aminotransferase. 5,6,7,8-Tetrahydro-8-deazahomofolic acid showed low substrate activity for thymidylate synthase .
|
-
-
- HY-CE01813
-
|
glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine-coenzyme A
|
Biochemical Assay Reagents
|
Metabolic Disease
|
|
Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine-CoA (Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanine-coenzyme A) is a coenzyme A derivative .
|
-
-
- HY-W016785S
-
-
-
- HY-CE01814
-
|
glycyl-L-alpha-amino-epsilon-pimelyl-D-alanyl-D-alanine-coenzyme A
|
Biochemical Assay Reagents
|
Metabolic Disease
|
|
Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanyl-D-alanine-CoA (Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanyl-D-alanine-coenzyme A) is a coenzyme A derivative .
|
-
-
- HY-P11675
-
-
- HY-179279
-
|
|
ADC Linker
|
Cancer
|
|
Mc-glycyl-L-valine(CO-PEG8)-L-alanine-benzenamine-CO-MeO-CO-N(Me)-o-toluic acid is an ADC Linker, and can be used for synthesis of ADCs .
|
-
- HY-108940R
-
|
|
Reference Standards
Aminoacyl-tRNA Synthetase
Bacterial
|
Infection
Cancer
|
|
GlyRS-IN-1 (Standard) is the analytical standard of GlyRS-IN-1 (HY-108940). This product is intended for research and analytical applications. GlyRS-IN-1 is a glycyl-tRNA synthase (GlyRS) inhibitor extracted from patent WO 2017066459 A1. GlyRS-IN-1 can also inhibit the growth of bacteria .
|
-
| Cat. No. |
Product Name |
Target |
Research Area |
-
- HY-W016887
-
|
H-Gly-Pro-OH; Gly-Pro
|
Endogenous Metabolite
Apoptosis
|
Metabolic Disease
Cancer
|
|
Glycyl-L-proline (H-Gly-Pro-OH) is a dipeptide. Glycyl-L-proline can induce MCF-7 cells apoptosis. Glycyl-L-proline can enhance the inhibitory effect of the PRODH/POX knockout on collagen and DNA biosynthesis. Glycyl-L-proline can inhibit Gly-Sar and L-proline transport. Glycyl-L-proline can be used for the researches of cancer and metabolic disease, such as breast cancer .
|
-
- HY-P0046
-
|
GHK; Tripeptide-1
|
Peptides
|
Neurological Disease
Inflammation/Immunology
|
|
Glycyl-L-histidyl-L-lysine is a tripeptide consisting of glycine, L-histidine and L-lysine residues joined in sequence. Glycyl-L-histidyl-L-lysine is a hepatotropic immunosuppressor and shows anxiolytic effect. Glycyl-L-histidyl-L-lysine and its copper complexes show good skin tolerance .
|
-
- HY-W009592
-
|
glycyltyrosine; Gly-Tyr; H-Gly-Tyr-OH
|
Amino Acid Derivatives
|
Others
|
|
Glycyl-L-tyrosine is a synthetic dipeptide that can be used as a food additive for tyrosine supplementation .
|
-
- HY-125616
-
|
Biotinyl-GHK; Bio-GHK
|
Amyloid-β
Reactive Oxygen Species (ROS)
|
Neurological Disease
|
|
Biotinoyl tripeptide-1 (Biotinyl-GHK) is a biotinylating reagent linked to a GHK (glycyl-L-histidyl-L-lysine) tripeptide. Biotin tripeptide-1 is a bioactive peptide with hair care (improves the appearance and feel of hair) and hair growth effects. Biotinoyl tripeptide-1 has a certain affinity for streptavidin. Biotinoyl tripeptide-1 inhibits the production of ROS and has antioxidant effects. Biotinoyl tripeptide-1 reduces the production of carbonylated amyloid-β (Aβ) and inhibits Aβ aggregation. Biotinoyl tripeptide-1 can be used in the study of neurodegenerative diseases .
|
-
- HY-W013998
-
-
- HY-W141910
-
-
- HY-W014000
-
-
- HY-W152604
-
|
Cyclo(leu-gly)
|
Dopamine Receptor
|
Neurological Disease
|
|
Cyclo(glycyl-L-leucyl) (Cyclo(leu-gly)), a neuropeptide, down-regulates dopamine (DA) receptors and attenuates dopaminergic supersensitivity. Cyclo(glycyl-L-leucyl) inhibits the development of Morphine induced pain relief as well as dopamine receptor supersensitivity in rats. Cyclo(glycyl-L-leucyl) has the potential for the prevention of tardive and/or L-DOPA (HY-N0304)-induced dyskinesias .
|
-
- HY-W014700
-
|
H-Gly-Glu-OH; Gly-Glu
|
Cholinesterase (ChE)
|
Neurological Disease
|
|
Glycyl-L-glutamic acid is a neurotrophic factor (NF) in vivo, and exerts function of maintenance of AChE content and activity. Glycyl-L-glutamic acid doesn’t act directly on AChE synthesis, and may prevent preganglionic neuronal degeneration .
|
-
- HY-W009592A
-
|
glycyltyrosine dihydrate; Gly-Tyr dihydrate; H-Gly-Tyr-OH dihydrate
|
Amino Acid Derivatives
|
Others
|
|
Glycyl-L-tyrosine dihydrate is a synthetic dipeptide that can be used as a food additive for tyrosine supplementation .
|
-
- HY-111922
-
|
glycyl-glycyl-L-proline; Gly-Gly-Pro
|
Peptides
|
Others
|
|
H-Gly-Gly-Pro-OH is a peptide with 3 amino acid.
|
-
- HY-W016887R
-
|
H-Gly-Pro-OH (Standard); Gly-Pro (Standard)
|
Reference Standards
Endogenous Metabolite
|
Metabolic Disease
|
|
H-Gly-Pro-OH (Standard) is the analytical standard of H-Gly-Pro-OH. This product is intended for research and analytical applications. H-Gly-Pro-OH is an end product of collagen metabolism that is further cleaved by prolidase.
|
-
- HY-P1930A
-
|
|
Integrin
|
Inflammation/Immunology
|
|
Risuteganib hydrochloride is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide. Risuteganib hydrochloride is an anti-integrin that downregulates oxidative stress and restores homeostasis, and targets three integrin receptors that are implicated in dry age-related macular degeneration (AMD) in order to restore homeostasis in the retina .
|
-
- HY-W013751
-
|
N-Fmoc-glycyl-L-valine
|
Drug Intermediate
|
Others
|
|
Fmoc-Gly-Val-OH (N-Fmoc-glycyl-L-valine) is a glycyl valine derivative, can be used for the synthesis of drugs or other compounds .
|
-
- HY-W013664
-
|
|
PROTAC Linkers
|
Cancer
|
|
Glycyl-l-serine is a PROTAC linker composed of glycine and serine. Glycyl-l-serine can be used in the synthesis of PROTACs, such as FPP29 (HY-P11228) .
|
-
- HY-W143241
-
-
- HY-148218
-
|
N-[(6S)-6-Carboxy-6-(glycylamino)hexanoyl]-D-alanyl-D-alanine
|
Amino Acid Derivatives
|
Metabolic Disease
|
|
Glycyl-L-alpha-amino-epsilon-pimelyl-D-alanyl-D-alanine is a specific peptide substrate of Streptomyces R1 d-alanyl-d-alanine(dd)-peptidases .
|
-
- HY-P1930
-
|
|
Integrin
|
Inflammation/Immunology
|
|
Risuteganib is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide. Risuteganib is an anti-integrin that downregulates oxidative stress and restores homeostasis, and targets three integrin receptors that are implicated in dry age-related macular degeneration (AMD) in order to restore homeostasis in the retina .
|
-
- HY-W273130
-
|
|
Biochemical Assay Reagents
|
Others
|
|
Glycyl-L-asparagine is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
|
-
- HY-W013998S
-
-
- HY-P11675
-
| Cat. No. |
Product Name |
Target |
Research Area |
Image |
-
- HY-P991158
-
|
|
TGF-β Receptor
|
Neurological Disease
|
|
Rinvatercept, a fusion protein, is a glycyl (1)-chimeric N-terminal (1-108)-peptide (2-109) combined from the sequences of the extracellular domains of the human ACVR2A/B, and is fused via a G3 peptide linker (110-112) to an immunoglobulin G1 (IgG1) Fc fragment. Rinvatercept can be used for research of neuromuscular disease .
|
-
(5)
| Cat. No. |
Product Name |
Category |
Target |
Chemical Structure |
| Cat. No. |
Product Name |
Chemical Structure |
-
- HY-128995AS
-
|
|
|
Glycyl-Exatecan-d5 (Glycyl-DX-8951-d5) hydrochloride is deuterium labeled Glycyl-Exatecan (HY-128995A). Glycyl-Exatecan (Glycyl-DX-8951), a derivative of Exatecan (HY-13631), is an anticancer agent. Glycyl-Exatecan has significantly antitumor activity. Glycyl-Exatecan can be used for cancers like solid tumors research.
|
-
-
- HY-144250S
-
|
|
|
Glycyl-L-proline- 15N,d2 (trifluoroacetate) is a 15N-labeled and deuterium labeled Glycyl-L-proline .
|
-
-
- HY-W013998S
-
|
|
|
Glycyl-L-phenylalanine-d2 is a deuterium labeled Glycyl-L-phenylalanine (HY-W013998). Glycyl-L-phenylalanine is a phenylalanine derivative.
|
-
-
- HY-A0052S
-
|
|
|
(1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide-d4 is deuterated labeled (1S,3aR,6aS)-(2S)-2-Cyclohexyl-N-(2-pyrazinylcarbonyl)glycyl-3-methyl-L-valyl-N-[(1R)-1-[2-(cyclopropylamino)-2-oxoacetyl]butyl]octahydrocyclopenta[c]pyrrole-1-carboxamide.
|
-
-
- HY-W016785S
-
|
|
|
Glycyl-L-valine- 13C5, 15N TFA is the 13C- and 15N-labeled Glycyl-L-valine (HY-W016785). Glycyl-L-valine is a dipeptide that contains glycine and valine .
|
-
Your information is safe with us. * Required Fields.
Inquiry Information
- Product Name:
- Cat. No.:
- Quantity:
- MCE Japan Authorized Agent: